Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
23.66
+0.67 (2.91%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $708.01 million as of July 26, 2024. Its market cap has decreased by -38.85% in one year.
Market Cap
708.01M
Enterprise Value
395.25M
1-Year Change
-38.85%
Ranking
Category
Stock Price
$23.66
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $708.01M, an increase of 352.40%. That is a compound annual growth rate of 21.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 688.00M | -19.69% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGM Biosciences | 684.67M |
| ArriVent BioPharma | 684.28M |
| Acelyrin | 683.29M |
| Exscientia | 678.20M |
| Ginkgo Bioworks Holdings | 672.29M |
| ProKidney | 667.89M |
| Mineralys Therapeutics | 666.28M |
| REGENXBIO | 664.96M |